Axcella to Present at Upcoming Investor Conferences
September 08 2020 - 8:00AM
Business Wire
Presentations and webcasts to take place on
September 14 and 15
Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company
focused on leveraging endogenous metabolic modulators (EMMs) to
pioneer a new approach for treating complex diseases and improving
health, today announced that management will be presenting at the
following upcoming conferences:
- H.C. Wainwright 22nd Annual Global Investment Conference, on
September 14, 2020, at 2:00 p.m. ET
- Cantor Virtual Global Healthcare Conference, on September 15,
2020, at 4:40 p.m. ET
Live audio webcasts of these presentations will be available on
the “Investors & News” section of the company’s website,
www.axcellahealth.com. Replays will also be available on Axcella’s
website for 30 days following the presentations.
Internet Posting of Information
Axcella uses its website, www.axcellahealth.com, as a means of
disclosing material nonpublic information and for complying with
its disclosure obligations under Regulation FD. Such disclosures
will be included on the company’s website in the “Investors &
News” section. Accordingly, investors should monitor this portion
of the company’s website, in addition to its press releases, SEC
filings and public conference calls and webcasts.
About Axcella
Axcella is a clinical-stage biotechnology company focused on
leveraging endogenous metabolic modulators (EMMs) to pioneer a new
approach for treating complex diseases and improving health. The
company’s product candidates are comprised of EMMs and their
derivatives that are engineered in distinct combinations and ratios
to simultaneously impact multiple biological pathways. Axcella’s
pipeline includes lead therapeutic candidates for non-alcoholic
steatohepatitis (NASH) and the reduction in risk of overt hepatic
encephalopathy (OHE) recurrence. Additional muscle- and
blood-related programs are in earlier-stage development. For more
information, please visit www.axcellahealth.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200908005074/en/
Investor Contact Jason Fredette
jfredette@axcellahealth.com 857.320.2236 Media Contact Azeem
Zeekrya HDMZ azeem.zeekrya@hdmz.com 312-506-5244
Axcella Health (NASDAQ:AXLA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Axcella Health (NASDAQ:AXLA)
Historical Stock Chart
From Apr 2023 to Apr 2024